KARE Biosciences

KARE Biosciences is a biotechnology company headquartered in Orange County, California, dedicated to repurposing drugs and discovering new small molecules to address unmet needs across various medical fields, including rare diseases. The company is currently developing Ramtreban for the treatment of acute and long-term COVID-19, thrombotic disorders, silicosis, sickle cell disease, pulmonary arterial hypertension, and other conditions. KARE Biosciences is also developing a novel antihypertensive combination, Indapamide, a best-in-class thiazide-like diuretic, for use in combination with a mineralocorticoid receptor antagonist (spironolactone or eplerenone). These combinations were patented by the company in 2010.